Siddharth Mittal succeeds Arun Chandavarkar as CEO, Joint MD of Biocon

Mittal has been serving as Chief Financial Officer of Biocon since August 2014

Siddharth Mittal
Siddharth Mittal, CEO, Biocon | Photo: company website
Press Trust of India New Delhi
1 min read Last Updated : Dec 03 2019 | 1:44 PM IST

Bengaluru-headquartered biopharmaceuticals company Biocon Ltd on Tuesday said Siddharth Mittal has taken over as its chief executive officer and joint managing director.

"Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the company starting December 1, 2019," the company said in a BSE filing.

Mittal has been serving as Chief Financial Officer (CFO) of Biocon since August 2014, the filing said.

Mittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30.

"I am very pleased to welcome Siddharth as CEO & Joint MD of Biocon," Biocon CMD Kiran Mazumdar-Shaw said.



 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Pharma sectorBioconKiran Mazumdar-Shaw

First Published: Dec 03 2019 | 11:55 AM IST

Next Story